Clinical Trial: A Multicenter, Prospective, Real-World Study on the Efficacy and Safety of Guselkumab in the Treatment of Inflammatory Bowel Disease (China)

China, Oct. 9 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Multicenter, Prospective, Real-World Study on the Efficacy and Safety of Guselkumab in the Treatment of Inflammatory Bowel Disease'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133921

Registration Time: 2026/10/09

Type: Observational study

Primary Sponsor: Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=311607

Published by HT Digital Content Services with permission from Health Daily Digest....